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Dietary intervention is an important approach in the prevention of cardiovascular disease. Over the last decade,
some studies have suggested that a calcium-rich diet could help to control body weight, with anti-obesity effects.
The potential mechanism underlying the impact of calcium on body fat has been investigated, but it is not fully
understood. Recent evidence has also suggested that a calcium-rich diet could have beneficial effects on other
cardiovascular risk factors, such as insulin resistance, dyslipidemia, hypertension and inflammatory states. In a series
of studies, it was observed that a high intake of milk and/or dairy products (the main sources of dietary calcium) is
associated with a reduction in the relative risk of cardiovascular disease. However, a few studies suggest that
supplemental calcium (mainly calcium carbonate or citrate) may be associated with an increased risk of
cardiovascular events. This review will discuss the available evidence regarding the relationship between calcium
intake (dietary and supplemental) and different cardiovascular risk factors and/or events.
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INTRODUCTION
Considerable evidence indicates the role of dietary
interventions in the prevention of cardiovascular disease
(CVD) (1). Existing research has focused mainly on the role
of macronutrients. However, micronutrients might also be
important in the prevention of CVD. The possibility that a
calcium-rich diet could affect energy balance, with anti-
obesity effects, has attracted considerable attention (2-3).
Several studies have also suggested that dietary calcium
could have beneficial effects on insulin resistance (4-8),
dyslipidemia (9-12), hypertension (13-18), inflammatory
stress (19-20) and cardiovascular events (21-24). In this
review, we discuss the evidence regarding calcium intake
and cardiovascular risk factors and/or events.
CALCIUM AND OBESITY
Observational studies
The initial evidence for an inverse association between the
intake of dietary calcium and/or dairy products (which are
the main sources of dietary calcium) and the parameters of
abdominal or total adiposity was derived from epidemio-
logical studies in both adults and children (9,25-26). Similar
results have been obtained from observational studies with
fewer participants, even when a specific group of indivi-
duals was evaluated (27-30). Two studies conducted by our
group observed this inverse association (28-29). In the first
study (28), a higher dietary calcium intake was associated
with lower total body adiposity in hypertensive patients,
whereas in the second study (29), a higher dietary calcium
intake was associated with lower abdominal adiposity in a
group of renal transplant patients.
A global evaluation of different observational studies
points to a modest negative association between dietary
calcium (or dairy) and body weight. Dougkas et al. (3),
based on a linear regression analysis of 18 studies, estimated
that at 400 mg of calcium/day (low dietary calcium intake),
a body mass index (BMI) of 25.6 kg/m2 was predicted,
while for 1,200 mg of calcium/day (adequate calcium
intake), a BMI of 24.7 kg/m2 was predicted. Thus, an
increase in calcium intake of 800 mg/day was associated
with a decrease in BMI of 1.1 kg/m2.
Interventional studies
The effect of calcium supplementation on weight loss is
uncertain. The results of randomized clinical trials designed
to examine the effects of calcium supplementation on
parameters of body fat have been ambiguous (31-36). One
factor that likely contributes to the conflicting results is the
lack of uniformity in the design of the studies. For example,
some trials used supplemental calcium (mainly calcium
carbonate or citrate) (37-40), while others used dietary
calcium (derived from dairy products) (34-36). In some
trials, calcium was supplemented during energy restriction
(37,40), while in others, energy intake was not restricted
(38-39).
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Among the studies without concomitant energy restric-
tion that evaluated the effects of supplemental calcium, the
majority did not observe any benefits to body weight and/
or composition (38-39,41). In contrast, some studies that
supplemented dietary calcium reported beneficial effects
(33,42). Zemel et al. (43) compared the effects of low dairy
(,1 dairy serving/day) versus recommended dairy (.3
servings/day) on weight maintenance and body composi-
tion subsequent to weight loss. Weight maintenance was
similar in both groups. However, the recommended dairy
group exhibited evidence of greater fat oxidation and was
able to consume greater amounts of energy without greater
weight gain compared to the low dairy group.
Studies that have evaluated the use of supplemental
calcium during energy restriction have failed to find
beneficial effects on weight loss (37,40). However, the
supplementation of dietary calcium associated with energy
restriction has induced significantly higher decreases in
total and/or abdominal adiposity in some studies (31-33,36)
but not in others (34-35). Recently, our group conducted a
randomized clinical trial (36) with 50 obese subjects of both
sexes, 22–55 years of age, with stable body weight and low
habitual calcium intake. The participants were randomized
into the following outpatient dietary regimens: (i) a low-
calcium diet (,500 mg/day) or (ii) a high-calcium diet
(1,200–1,300 mg/day, supplemented with non-fat powdered
milk [60 g/day]). Both groups followed an energy-restricted
diet (-800 kcal/day) throughout the study (16 weeks). After
16 weeks of energy restriction, the subjects on the high-
calcium diet exhibited greater reductions in waist circum-
ference (p= 0.002) and waist-to-hip ratio (p= 0.0001) than the
subjects on the low-calcium diet (36).
Studies comparing the effects of supplemental versus
dietary calcium during energy restriction have observed
that calcium from dairy products has a greater effect on the
reduction of body fat (31,44). According to Van Loan (45),
three important elements have been present in studies
showing a favorable effect of calcium and/or dairy pro-
duct intake on weight loss. First, all of the individuals
participating in these studies were overweight and/or
obese. Second, the subjects’ calcium intake levels were
habitually inadequate (,600 mg/day), and an appropriate
control group (,600 mg of calcium/day) was used. Third,
moderate energy restriction was maintained throughout
the study.
Interventional trials assessing the effects of calcium
supplementation on body adiposity present inconsistent
results, and further studies regarding this issue are needed.
Possible mechanisms underlying the impact of
calcium on adiposity
The mechanisms underlying the possible relationship
between calcium and/or dairy intake and BMI are unclear.
However, a reduction in body weight can only occur if fecal
energy loss, energy expenditure and/or energy intake are
affected. High calcium intake has been suggested to affect
all of these factors (46).
Effect of calcium on fat metabolism in adipocytes
There is evidence from in vitro and animal studies that
increased calcium intake inhibits lipogenesis and stimulates
lipolysis and thermogenesis, thereby increasing energy
expenditure and lipid oxidation (46). One of the suggested
mechanisms that explains these effects is that low calcium
intake raises serum levels of calcitriol (1,25(OH)2 vitamin D),
which can stimulate adipocyte calcium influx by membrane
vitamin D receptors, identified as the membrane-associated
rapid response to steroids (1,25D MARRS). This increase in
intracellular calcium levels ([Ca2+]i) might promote lipogen-
esis and inhibit lipolysis by increasing fatty acid synthase
activity and expression inhibiting hormone-sensitive lipase
(2,47). Calcitriol also acts via the classical nuclear vitamin D
receptors in adipocytes to inhibit the expression of
uncoupling protein-2 and thus increase energy efficiency.
Calcitriol regulation of uncoupling protein-2 and [Ca2+]i
appears to exert an additional effect on energy metabolism
by affecting adipocyte apoptosis (2). In contrast, an increase
in calcium intake can decrease serum levels of calcitriol,
consequently reducing lipogenesis and stimulating lipolysis
(46).
Effect of calcium on fecal fat excretion
Although it has already been shown that both dietary and
supplemental calcium can increase fecal fat excretion
through the formation of insoluble complexes (soaps), there
is disagreement regarding the magnitude of this effect (2,47-
48). In general, the effect is relatively small (especially with
supplemental calcium), and studies have used amounts of
calcium that are higher than the usual intakes of different
populations and also higher than the amounts of calcium
used in studies evaluating the effects of calcium on
adiposity (48-49).
In a recent meta-analysis (49), an increase in dairy calcium
intake of approximately 1,200 mg/day resulted in an
increase in fecal fat excretion of 5.2 g/day. Astrup et al.
(46), assuming that increased fat excretion of 3,500 kcal/year
produces weight loss of 0.45 kg/year, estimated that this
would correspond to a weight change of -2.2 kg/year.
According to these authors (46), this effect is sufficient to
explain the differences found in observational studies but
not in some interventional trials. In summary, this mechan-
ism probably contributes to the anti-obesity effect of calcium
but cannot explain it completely (2,47-48).
Effect of calcium on appetite regulation
Recently, it was suggested that calcium intake could
interfere in the regulation of appetite. However, this effect
was evaluated in a very small number of studies, and this
hypothesis is not confirmed (3,46). In humans, only two
studies have been conducted (50-51). Major et al. (50) found
that daily supplementation of 1,200 mg of calcium + 10 mcg
of vitamin D for 15 weeks in subjects with low habitual
calcium intake (,600 mg/day) resulted in decreased ad
libitum lipid intake. These authors speculated that the co-
occurrence of fats and calcium in an abundance of food,
especially dairy foods, could influence subjects with
habitual low calcium intake toward the selection of high-
fat foods (50). In contrast, Lorenzen et al. (51) found that
acute ingestion of dietary and/or supplemental calcium has
no effect on postprandial appetite, the levels of hormones
involved in the regulation of appetite or energy intake at
subsequent meals.
Effect of calcium on abdominal obesity
Observational studies (27,29) and randomized clinical
trials (31-33,36) have indicated that a high-calcium diet is
associated with a significantly greater decrease in abdominal
obesity, suggesting body fat redistribution. The exact
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mechanism by which dietary calcium intake induces
abdominal obesity reduction is still not clear, although
recent studies describing the role of adipose tissue autocrine
cortisol production could provide a plausible explanation
(2). Human adipose tissue expresses 11b-hydroxysteroid
dehydrogenase-1, which catalyzes the conversion of corti-
sone to cortisol. Recently, it was demonstrated that calcitriol
stimulates the expression of 11b-hydroxysteroid dehydro-
genase-1 and cortisol production by human adipocytes.
Because high-calcium diets suppress calcitriol levels, it has
been suggested that the decrease in central obesity seen
with these diets could be partly explained by the suppres-
sion of calcitriol levels, leading to a reduction of adipocyte
cortisol production (52).
CALCIUM AND INSULIN RESISTANCE
The association is relatively consistent between low
calcium (and/or dairy) intake and the increased prevalence
of type 2 diabetes and/or insulin resistance (4) and has been
found in several observational cohort studies (5-8). Pittas et
al. (5) followed 83,779 women participating in the Nurses’
Health Study for 20 years and identified a multivariate
relative risk of type 2 diabetes of 0.79 (95% CI 0.70 – 0.90;
p,0.001) when comparing the highest category of calcium
intake with the lowest category (dietary + supplemental). In
prospective data from 41,254 men taking part in the Health
Professionals Follow-up Study who were followed for 12
years, intake of dairy products was associated with a
modestly lower risk of type 2 diabetes (6).
Despite the epidemiological findings, there is only limited
evidence regarding the effects of calcium supplementation
on insulin sensitivity (4). The results of studies with
supplemental calcium appear to have been influenced by
the level of insulin sensitivity at baseline. In a study by
Pittas et al. (53), combined daily supplementation of vitamin
D (700 IU) + calcium (500 mg) for three years only produced
a significant improvement in insulin sensitivity in subjects
with impaired glucose tolerance at baseline.
The exact mechanism by which calcium modulates
insulin resistance is not known (4). There is evidence that
an increase in [Ca2+]i in adipocytes and other insulin target
cells, induced by a low-calcium diet, can result in insulin
resistance via phosphorylation of glucose transporter type 4
(GLUT-4) and other substrates sensitive to insulin, render-
ing glucose uptake mediated by insulin less efficient (54).
CALCIUM AND DYSLIPIDEMIA
The effects of calcium on lipid profiles have not yet been
elucidated. Some studies using dietary or supplemental
calcium have found significant reductions in total choles-
terol and low-density lipoprotein (LDL) cholesterol or
increases in high-density lipoprotein (HDL) cholesterol
(10-12), while other studies have not found such benefits
(39,55).
In the gut, saponification of free fatty acids by calcium
reduces the intestinal absorption of lipids; this mechanism
can explain the effects of calcium on lipid profiles (10,12).
This reduction in the absorption of fatty acids, especially
saturated fatty acids, could reduce serum cholesterol levels
by decreasing the production of very low-density lipopro-
tein (VLDL) and by increasing the uptake of LDL cholesterol
by the liver. Calcium can also bind to bile acids, increasing
fecal excretion and thus favoring the conversion of
cholesterol into bile acids (56).
CALCIUM AND HYPERTENSION
An inverse relationship between calcium and/or dairy
intake and blood pressure has been reported in various
epidemiological studies, typically showing that reduced
intake of calcium is associated with higher blood pressure
and/or an increased risk of developing hypertension (13-
16).
The randomized clinical trials that have evaluated the
effects of calcium supplementation have identified modest
reductions in blood pressure (17-18). vanMierlo et al. (17)
performed a meta-analysis of 40 randomized controlled
trials evaluating the effects of calcium supplementation
(mean daily dose: 1,200 mg) and found significant reduc-
tions in systolic (-1.86 mm Hg) and diastolic (-0.99 mm Hg)
blood pressure. Calcium supplementation has a greater
hypotensive effect on: (i) subjects regularly consuming small
amounts of calcium (17); (ii) hypertensive individuals or
groups at a higher risk of developing hypertension, such as
individuals with sub-Saharan African ancestry, salt-sensi-
tive persons and pregnant women (57); and (iii) studies
using dietary calcium (18).
Reid et al. (39) conducted a randomized controlled trial of
calcium supplementation in 323 generally healthy men over
a period of two years. The subjects were assigned to groups
taking a placebo, 600 mg of calcium/day, or 1,200 mg of
calcium/day. There were downward trends in systolic and
diastolic blood pressures within the calcium-supplemented
groups, but there were no significant treatment effects over
the entire trial period (p.0.60). In a post hoc analysis of those
subjects with baseline calcium intakes less than the median
value (785 mg/day), their blood pressures exhibited border-
line treatment effects (p= 0.05–0.06 for changes at two years
in those subjects who received 1,200 mg of calcium/day
compared with those taking a placebo: systolic, -4.2 mm Hg;
diastolic, -3.3 mm Hg).
To date, the evidence available provides the basis for the
argument that a diet containing the recommended amounts
of dairy products can reduce the risk of hypertension (57).
The protective effect of calcium on blood pressure can be
partly explained by the influence of calcitriol on [Ca2+]i. An
increase of [Ca2+]i in vascular smooth muscle cells can result
in vasoconstriction and a consequent rise in blood pressure
(58-59).
CALCIUM AND INFLAMMATORY STRESS
Some studies have suggested that calcium intake can
facilitate the suppression of the inflammatory state associated
with obesity (19-20). Few studies have been conducted in
humans (20,60), and these studies have evaluated only the
effects of dietary calcium. Zemel et al. (20) conducted a study
to assess the acute effects of a diet rich in dairy products on
inflammatory stress in obese and overweight subjects in the
absence of changes in adiposity. In this randomized, blinded,
crossover trial, normocaloric diets were supplemented with
dairy or soy over two periods of 28 days, separated by a
washout period of 28 days. The diet supplemented with dairy
products resulted in significantly lower levels of inflamma-
tory markers (tumor necrosis factor-a, interleukin-6 and
monocyte chemotactic protein-1) and significantly increased
levels of adiponectin (20%) (20).
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The modulation of inflammatory stress by calcium is
likely mediated, in part, by a reduction in body fat.
However, it has been shown that calcium could have
additional effects via the suppression of calcitriol (20).
Elevated serum levels of calcitriol, in addition to increasing
[Ca2+]i, appear to increase the production of reactive oxygen
species (ROS) through the modulation of mitochondrial
uncoupling. These two mechanisms modulate the produc-
tion and release of cytokines (19-20).
ADDITIONAL BIOACTIVE COMPONENTS OF DAIRY
PRODUCTS
Dairy products have other bioactive components (in
addition to calcium) that can have beneficial effects on
adiposity and/or cardiovascular risk factors, such as leucine
and the peptides that inhibit angiotensin-converting
enzyme (ACE) (2). The high concentrations of leucine
present in dairy products can contribute to the anti-obesity
effects of these foods by stimulating muscle protein
synthesis, inhibiting muscle degradation, and suppressing
the energy storage of adipose tissue (61). The peptides that
inhibit ACE, found in dairy whey, could contribute to the
beneficial effects of dairy products on adiposity, blood
pressure and inflammatory stress (2,20).
CALCIUM AND CARDIOVASCULAR EVENTS
The relationship between calcium intake and the risk of
cardiovascular events has been explored in some studies
(21-24,62-65). The results of studies evaluating dietary
calcium differ from studies evaluating supplemental cal-
cium. Thus, these studies will be discussed separately.
Supplemental calcium and cardiovascular events
The results of studies assessing the effects of supple-
mental calcium on cardiovascular events are inconsistent.
Supplemental calcium is widely recommended for post-
menopausal women to prevent osteoporosis. The effects of
this supplementation on bone mineral density and fracture
risk have been investigated in numerous studies. Secondary
analyses of the data from a few of these studies suggest that
supplemental calcium (with or without co-administered
vitamin D) might be associated with an increased risk of
cardiovascular events, especially acute myocardial infarc-
tion (63-64,66). Bolland et al. (63) conducted a randomized
clinical trial to evaluate the effects of calcium supplementa-
tion (1 g of elemental calcium daily, as citrate) on
myocardial infarction, stroke, and sudden death in healthy
postmenopausal women. The study included 1471 women
(mean age of 74 years old): 732 were randomized to calcium
supplementation and 739 to placebo. The composite end
points of myocardial infarction, stroke, and sudden death
were more common in the calcium group (p= 0.008). The
authors concluded that calcium supplementation in post-
menopausal women is associated with upward trends in
cardiovascular risk.
Despite the potential harmful effects of supplemental
calcium observed in the studies cited above, other authors
do not agree with this point of view (67-69). Several studies
have found no increased risk of CVD with calcium
supplementation (with or without vitamin D) in postmeno-
pausal women (65,70-74).
Lewis et al. (65) found no increased risk of atherosclerotic
CVD with daily calcium supplementation of 1,200 mg.
Mursu et al. (70) assessed the use of vitamin and mineral
supplements in relation to total mortality in 38,772 older
women in the Iowa Women’s Health Study; the mean age
was 61.6 years old at baseline in 1986. Supplement use was
self-reported in 1986, 1997, and 2004. Through December 31,
2008, a total of 15,594 deaths (40.2%) were identified.
Supplemental calcium was inversely correlated with total
mortality rate (hazard ratio, 0.91; 95% CI, 0.88-0.94; absolute
risk reduction, 3.8%); however, no clear dose-response
relationship was observed.
Shah et al. (71) investigated the long-term cumulative
effects of calcium and vitamin D supplementation on
cardiovascular outcomes and death in older women. An
observational cohort study using a UK electronic primary
care records database was referenced; 9,910 women aged
60–89 years old were studied who began calcium and
vitamin D supplementation between 2000 and 2005, with no
heart disease or stroke history and who survived disease-
free for two years after supplement initiation. Two years
after initiation, the women who consistently received
supplementation with calcium and vitamin D did not
experience more cardiovascular events or deaths than the
women who received minimal supplementation.
The proposed mechanism for the increased risk of
atherosclerotic disease is the acute rise in serum calcium
that can be induced with supplemental calcium (but not
with dietary calcium). There is epidemiological evidence
that serum levels of calcium in the upper limit of the normal
range are a risk factor for vascular disease (62).
Dietary calcium and cardiovascular events
In a series of studies, it has been observed that high intake
of milk and/or dairy products is associated with a reduction
in the relative risk of CVD (21-24). In a recent meta-analysis,
Elwood et al. (22) observed that the relative risks for stroke
and coronary heart disease in individuals with high intake
levels of milk and dairy products were 0.84 (95% CI 0.76-
0.93) and 0.79 (95% CI 0.75-0.82), respectively, compared
with subjects with low intakes.
FINAL CONSIDERATIONS
Epidemiological studies indicate an inverse association
between calcium intake and total or abdominal adiposity,
insulin resistance, and blood pressure. In contrast, the effects
of calcium supplementation (either dietary or supplemental)
on obesity and cardiovascular risk factors have not been
proven. The most consistent findings indicate modest
benefits of dietary calcium (especially in individuals with
low habitual intake of this mineral) in the reduction of
adiposity during periods of energy restriction and in the
reduction of blood pressure.
The relationship between calcium intake and cardiovas-
cular events is uncertain. High levels of intake of milk and/
or dairy products have been associated with a reduction in
the relative risk of CVD in a series of studies. However,
supplemental calcium has been associated with increased
risk of cardiovascular events in some trials. Further studies
are needed to define the effects of calcium intake on
cardiovascular risk factors and/or events.
Calcium and cardiovascular disease
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